VOLUMETRIC ASSESSMENT AND STRATIFICATION OF PATIENT SURVIVAL WITH EARLY POST-TREATMENT MRI IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB

被引：0
|
作者：
Huang, Raymond [1 ,3 ]
Rahman, Rifaquat [3 ]
Hamdan, Alhafidz [2 ]
Kane, Caroline [2 ]
Chen, Christina [3 ]
Norden, Andrew [2 ,3 ]
Reardon, David [2 ,3 ]
Mukundan, Srinivasan [1 ,3 ]
Wen, Patrick [2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] Recurrent Glioblastoma Volumetric Assessment and Stratification of Patient Survival With Early Posttreatment Magnetic Resonance Imaging in Patients Treated With Bevacizumab
    Huang, Raymond Y.
    Rahman, Rifaquat
    Hamdan, Alhafidz
    Kane, Caroline
    Chen, Christina
    Norden, Andrew D.
    Reardon, David A.
    Mukundun, Srinivasan
    Wen, Patrick Y.
    [J]. CANCER, 2013, 119 (19) : 3479 - 3488
  • [2] Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin
    Bennett, Iwan E.
    Field, Kathryn M.
    Hovens, Christopher M.
    Moffat, Bradford A.
    Rosenthal, Mark A.
    Drummond, Katharine
    Kaye, Andrew H.
    Morokoff, Andrew P.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (02) : 321 - 329
  • [3] Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin
    Iwan E. Bennett
    Kathryn M. Field
    Christopher M. Hovens
    Bradford A. Moffat
    Mark A. Rosenthal
    Katharine Drummond
    Andrew H. Kaye
    Andrew P. Morokoff
    [J]. Journal of Neuro-Oncology, 2017, 131 : 321 - 329
  • [4] Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab
    Ellingson, Benjamin M.
    Cloughesy, Timothy F.
    Lai, Albert
    Nghiemphu, Phioanh L.
    Mischel, Paul S.
    Pope, Whitney B.
    [J]. NEURO-ONCOLOGY, 2011, 13 (04) : 401 - 409
  • [5] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
    Hamza, Mohamed A.
    Mandel, Jacob J.
    Conrad, Charles A.
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    DeGroot, John F.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (01) : 135 - 140
  • [6] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
    Mohamed A. Hamza
    Jacob J. Mandel
    Charles A. Conrad
    Mark R. Gilbert
    W. K. Alfred Yung
    Vinay K. Puduvalli
    John F. DeGroot
    [J]. Journal of Neuro-Oncology, 2014, 119 : 135 - 140
  • [7] Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
    Prados, Michael
    Cloughesy, Timothy
    Samant, Meghna
    Fang, Liang
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Das, Asha
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2011, 13 (01) : 143 - 151
  • [8] Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab
    Grossmann, Patrick
    Narayan, Vivek
    Chang, Ken
    Rahman, Rifaquat
    Abrey, Lauren
    Reardon, David A.
    Schwartz, Lawrence H.
    Wen, Patrick Y.
    Alexander, Brian M.
    Huang, Raymond
    Aerts, Hugo J. W. L.
    [J]. NEURO-ONCOLOGY, 2017, 19 (12) : 1688 - 1697
  • [9] Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
    Hamza, Mohamed Ali
    Mandel, Jacob
    Conrad, Charles A.
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    De Groot, John Frederick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment
    Sever, Ozlem Nuray
    Oktay, Kadir
    Guzel, Ebru
    Kaya, Vildan
    Guzel, Aslan
    Yildirim, Mustafa
    [J]. INDIAN JOURNAL OF CANCER, 2021, 58 (01) : 91 - 95
12345